Alitretinoin Articles
Better times ahead for Switzerland’s Basilea
26 October 2009
Stock Commentary - Europe - week to mar 30, 2009
2 April 2009
Stock Commentary - Europe - week to Mar 9, 2009
16 March 2009
Basilea's Toctino cleared by SMC
16 March 2009
UK release for Basilea's Toctino
22 September 2008
Basilea eczema drug's UK price twice estimate
15 September 2008
ABPI joined by 16 new members in 1H 2008
4 August 2008
Basilea's 2007 loss up 55% on trial costs
18 February 2008
Opposite ratings for Swiss bio firms Arpida and Basilea
8 October 2007
Basilea to raise funds through share offer
26 March 2007
Japan stock market week to Oct 30, 2006
6 November 2006
Ligand finalizes sale of oncology line to Eisai
6 November 2006
Japan stock market week to Sept 11, 2006
18 September 2006
Ligand sells oncology line to Eisai and Avinza to King for total $518M
18 September 2006
Ligand sets up pain and oncology units
15 November 2004
R&D costs offset 140% sales rise at Ligand
18 August 2003
Ligand's 2nd-qtr revenues up 10%, despite 15% loss growth
19 August 2002
Ligand revenues leap 59%, as product sales double
18 March 2002
Ligand's Panretin gel OKed in Europe
26 October 2000
Ligand gains CPMP backing for Panretin gel
20 July 2000
Ligand sells Marathon assets for $10 million
11 January 2000
Ligand completes marketing deal in Italy
7 January 2000
Busy year for NCEs as major new compound classes launched
6 January 2000
Ligand Panretin news
22 June 1999
FDA approves Ligand's Ontak for cutaneous T cell lymphoma
11 February 1999
Ligand's Panretin approved by FDA
4 February 1999
Ligand forms new international unit
13 January 1999
Ligand's Panretin Gel Gets FDA Approvable Letter
2 December 1998
Ligand's Panretin NDA Recommended To FDA
26 November 1998
Ligand Takes $30 Mill 3rd-Qtr Charge
20 November 1998
ALRT Buyback Affects Revenues At Ligand
24 August 1998
Ligand Files Panretin NDA
28 May 1998
Ph III Panretin Data, IND Filed For TSE-424
2 April 1998
Scherer Working With Ligand On Softgel Products
9 March 1998
Oncology News In Brief
4 March 1998
Ligand's Panretin Capsules In KS
19 February 1998
Ligand To Submit NDA For Panretin Gel 1Q98
18 December 1997
9% Rise In Nine-Month Revenues For Ligand
18 November 1997
Research Collaboration For Allergan and ACADIA
29 September 1997
Ph I/IIa Trial Data With Oral Panretin
4 September 1997
Panretin Trial Halted On Positive Results
27 August 1997
Allergan Announces R&D Pipeline Developments
5 May 1997
ALRT Presents New Drug Candidates At H&Q
20 January 1997
Showing 1-51 of 51 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
